Jazz Pharmaceuticals plc — Director's Dealing 2014

Jul 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-07-07

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-07	Ordinary Shares	M	2500	$27.46	Acquired	26169	Direct
2014-07-07	Ordinary Shares	S	2500	$165.00	Disposed	23669	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-07	Incentive Stock Option (right to buy)	$27.46	M	2500	Disposed	2021-03-09	Ordinary Shares (2500)	Direct

Footnotes

F1: Includes 257 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 30, 2014.

F2: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: Following the reported transaction, the remaining ordinary shares subject to this option vested with respect to 6,905 shares and will vest with respect to 1,518 shares in equal monthly installments from August 7, 2014 to December 7, 2014 and with respect to 2,084 shares in equal monthly installments from January 7, 2015 to February 7, 2015.